Wuxi Apptec 药明康德
12 significant filings since 29 May 2026: 5 on equity incentive, 4 on buyback and 3 on dividend. The latest, on 28 Aug 2026: 2026年半年度A股权益分派实施公告.
自 29 May 2026 起有 12 份重大公告：equity incentive 5 份、buyback 4 份、dividend 3 份。最新一份（28 Aug 2026）：2026年半年度A股权益分派实施公告。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 7.15 | 8.63 |
| 7 days ago | 7.15 | 8.63 |
| 30 days ago | 7.15 | 8.63 |
| 60 days ago | 5.83 | 6.95 |
| 90 days ago | 5.81 | 6.88 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 4.18 in Sep 2024 to 7.15 in Sep 2026 (+71.1%). 一致预期从 Sep 2024 的 4.18 变为 Sep 2026 的 7.15 (+71.1%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 5 ▼ 0 = 0 | ▲ 5 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2021 | 24 Mar 2022 | 1.72 | 6 | 1.75 | +1.6% |
| FY2020 | 31 Mar 2021 | 1.19 | 4 | 1.06 | -10.5% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 0.